New cholesterol guidelines: worth the wait? - Wikidata - wikimedia - TriplyDB

New cholesterol guidelines: worth the wait?

New cholesterol guidelines: worth the wait?

http://www.wikidata.org/entity/Q33603183

about

Timing of Administration: For Commonly-Prescribed Medicines in Australia Dyslipidemia management in primary prevention of cardiovascular disease: Current guidelines and strategies Clinical Characteristics and Unmet Need Among Patients with Atherosclerotic Cardiovascular Disease Stratified by Statin Use Moneyball, gambling, and the new cholesterol guidelines.Implications of the US cholesterol guidelines on eligibility for statin therapy in the community: comparison of observed and predicted risks in the Framingham Heart Study Offspring Cohort.Cholesterol and prevention of atherosclerotic events: limits of a new frontier.Risks and benefits of statin use in young people with type 1 diabetes.Clinical characteristics, patterns of lipid-lowering medication use, and health care resource utilization and costs among patients with atherosclerotic cardiovascular disease.Situational Analysis of Low-density Lipoprotein Cholesterol Control and the Use of Statin Therapy in Diabetes Patients Treated in Community Hospitals in Nanjing, China.Effect of metformin monotherapy on serum lipid profile in statin-naïve individuals with newly diagnosed type 2 diabetes mellitus: a cohort study.Cholesterol treatment patterns and cardiovascular clinical outcomes associated with colesevelam HCl and ezetimibe

P2860

Q26752357-DBB2DB3D-A554-4E43-8C41-4427DA687927 Q26765157-01B6869D-8943-47CA-B6F8-F0D2DA62DCDB Q33572803-EFC36BE0-C3F3-4E48-9238-1CF99E5F2198 Q33631548-0A040136-044D-4DA4-AE05-A0CEF119DD6D Q36085712-71C8023E-84A5-44D9-BE40-3DF7EFD598B9 Q37603367-2A6C2BCC-5C1E-44BB-87ED-41771421F737 Q38209424-D645E3F5-81E9-4A02-B42F-2F39EC3E7AFE Q49707495-24815966-E531-4E23-B8F9-D9471663736A Q49831991-EB71719E-3C16-4A97-88A6-B7A42DC438AF Q55314889-31A68F7E-8703-4018-8AFE-FB31D5C9A97B Q57150144-27836B6F-2AE6-43BB-941C-66ADAF881702

P2860

New cholesterol guidelines: worth the wait?

http://www.wikidata.org/entity/Q33603183

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

name

New cholesterol guidelines: worth the wait?

@ast

New cholesterol guidelines: worth the wait?

@en

type

label

New cholesterol guidelines: worth the wait?

@ast

New cholesterol guidelines: worth the wait?

@en

prefLabel

New cholesterol guidelines: worth the wait?

@ast

New cholesterol guidelines: worth the wait?

@en

P1433

Q33603183-24023F1D-9623-4BAF-890C-0B3D24A98A05

P1476

Q33603183-B20B997B-FDF1-402F-8C38-44C41362D4B1

P2093

Q33603183-02BE06B2-7A4E-4FDA-A52C-21987EFD43D7

Q33603183-28B78B0C-4265-49DF-8EF7-0F313A7E86CE

Q33603183-525898EB-8AA3-48D9-B427-02D87062D6C1

Q33603183-9055716B-7D78-446B-ADC2-2A61D7D15783

P2860

Q33603183-0BC5695B-A15A-4EAF-98D3-ED56A719275F

Q33603183-0DB4C4D3-81B4-4263-B9CA-BDBC673C94D8

Q33603183-17BF81F1-4536-4CFC-A63E-70DFB207DABE

Q33603183-2272BAF0-33F8-4F75-B81F-53D4596C07A6

Q33603183-234218EB-635B-4ED5-A58C-84253E461061

Q33603183-2B5C8269-80EF-479E-B8BB-D7457BB03F66

Q33603183-2B6396A3-19B4-42E9-AC11-C8BBFFD9FF43

Q33603183-2F35C0C1-AAF3-46CC-B11B-A37CB3976C27

Q33603183-4813CEE9-51AE-4208-AAA1-29394FA94E23

Q33603183-54AC6564-47C1-4142-9731-DDE178669D20

P304

Q33603183-E9FB4F1A-B5E6-43BE-9A67-8EE87C8862F1

P31

Q33603183-CCC21498-E037-4176-AC41-8EF16B48663D

P356

Q33603183-DA75D1CE-AC34-4082-9A47-48BEF239F095

P433

Q33603183-8E6FD3F2-828B-4F0D-B283-D08FE84A2B6A

P478

Q33603183-8B809D56-9192-4E53-A08C-D0D959911BF1

P577

Q33603183-965CB7B5-2F2F-465C-A01A-DADD7450F672

P698

Q33603183-93DA91DC-15D1-408D-A9D0-A96C8013FA2F

P932

Q33603183-B64B8EF7-E705-4F04-8730-345920389F3C

P356

P1433

Cleveland Clinic Journal of Medicine

P1476

New cholesterol guidelines: worth the wait?

@en

P2093

Chad Raymond

http://www.w3.org/2001/XMLSchema#string

Leslie Cho

http://www.w3.org/2001/XMLSchema#string

Michael Rocco

http://www.w3.org/2001/XMLSchema#string

Stanley L Hazen

http://www.w3.org/2001/XMLSchema#string

P2860

The LDL receptor

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

The Cardiovascular Health Study: design and rationale

The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Standards of medical care in diabetes--2013

Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

P304

11-19

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3949/CCJM.81A.13161

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24391101

http://www.w3.org/2001/XMLSchema#string

P932

4019214

http://www.w3.org/2001/XMLSchema#string